A qualitative assessment of anabolic-androgenic steroid use among gym users in Jordan: motives, perception, and safety.


Journal

International journal of legal medicine
ISSN: 1437-1596
Titre abrégé: Int J Legal Med
Pays: Germany
ID NLM: 9101456

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 26 05 2023
accepted: 14 06 2023
medline: 14 8 2023
pubmed: 25 6 2023
entrez: 24 6 2023
Statut: ppublish

Résumé

Over the years, the use of anabolic-androgenic steroids (AAS) has become widespread among athletes and bodybuilders. The prevalence of their use has been estimated at around 20 to 50% globally. Unfortunately, many athletes do not have the proper knowledge about the effects of these banned substances Thus, this study aims to qualitatively assess Jordanian gym users' AAS intentions, perceptions, and safety. Twenty male Jordanian anabolic steroid users were interviewed using in-depth interviews as part of a qualitative study evaluating the motivations, perceptions, and safety of AAS among gym users. The findings of this study indicate that the desire to compete in bodybuilding contests was the primary motivation for participants to use AAS. The study participants mentioned using a combination of oral and injectable medications. Gym coaches and trainers were also identified as an essential source of information for AAS use. A very limited number of AAS users were getting their information from healthcare providers, and most of them have experienced some of these medications side effects but are still willing to continue the use of AAS to get what they need in terms of their physical appearance or for winning competitions. There is an urgent need for structured awareness campaigns targeting gyms and fitness clubs' members to increase their knowledge about the side effects and health risks associated with the use of AAS. In addition, sports governing bodies should have stricter measures to tackle this problem and discourage athletes from using such products.

Sections du résumé

BACKGROUND BACKGROUND
Over the years, the use of anabolic-androgenic steroids (AAS) has become widespread among athletes and bodybuilders. The prevalence of their use has been estimated at around 20 to 50% globally. Unfortunately, many athletes do not have the proper knowledge about the effects of these banned substances Thus, this study aims to qualitatively assess Jordanian gym users' AAS intentions, perceptions, and safety.
METHODS METHODS
Twenty male Jordanian anabolic steroid users were interviewed using in-depth interviews as part of a qualitative study evaluating the motivations, perceptions, and safety of AAS among gym users.
RESULTS RESULTS
The findings of this study indicate that the desire to compete in bodybuilding contests was the primary motivation for participants to use AAS. The study participants mentioned using a combination of oral and injectable medications. Gym coaches and trainers were also identified as an essential source of information for AAS use. A very limited number of AAS users were getting their information from healthcare providers, and most of them have experienced some of these medications side effects but are still willing to continue the use of AAS to get what they need in terms of their physical appearance or for winning competitions.
CONCLUSION CONCLUSIONS
There is an urgent need for structured awareness campaigns targeting gyms and fitness clubs' members to increase their knowledge about the side effects and health risks associated with the use of AAS. In addition, sports governing bodies should have stricter measures to tackle this problem and discourage athletes from using such products.

Identifiants

pubmed: 37355480
doi: 10.1007/s00414-023-03046-6
pii: 10.1007/s00414-023-03046-6
doi:

Substances chimiques

Anabolic Androgenic Steroids 0
Anabolic Agents 0
Testosterone Congeners 0
Steroids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1421-1430

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Kanayama G, Hudson JI, Pope HG Jr (2010) Illicit anabolic-androgenic steroid use. Horm Behav 58:111–121. https://doi.org/10.1016/j.yhbeh.2009.09.006
doi: 10.1016/j.yhbeh.2009.09.006 pubmed: 19769977
Pope H, Brower K (2009) Anabolic-androgenic steroid-related disorders. Compr Textbook Psychiatry 9:1419–1431
Hildebrandt T, Langenbucher JW, Carr SJ, Sanjuan P (2007) Modeling population heterogeneity in appearance-and performance-enhancing drug (APED) use: applications of mixture modeling in 400 regular APED users. J Abnorm Psychol 116:717
doi: 10.1037/0021-843X.116.4.717 pubmed: 18020718
Denham BE (2004) Sports Illustrated, the mainstream press and the enactment of drug policy in Major League Baseball: a study in agenda-building theory. Journalism 5:51–68
doi: 10.1177/1464884904039554
Achar S, Rostamian A, Narayan SM (2010) Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. Am J Cardiol 106:893–901
doi: 10.1016/j.amjcard.2010.05.013 pubmed: 20816133 pmcid: 4111565
Mooradian AD, Morley JE, Korenman SG (1987) Biological actions of androgens. Endocr Rev 8:1–28
doi: 10.1210/edrv-8-1-1 pubmed: 3549275
Clark AS, Henderson LP (2003) Behavioral and physiological responses to anabolic-androgenic steroids. Neurosci Biobehav Rev 27:413–436
doi: 10.1016/S0149-7634(03)00064-2 pubmed: 14505684
Middleman AB, DuRant RH (1996) Anabolic steroid use and associated health risk behaviours. Sports Med 21:251–255
doi: 10.2165/00007256-199621040-00001 pubmed: 8726343
de Ronde W, Smit DL (2020) Anabolic androgenic steroid abuse in young males. Endocr Connect 9:R102–R111. https://doi.org/10.1530/ec-19-0557
doi: 10.1530/ec-19-0557 pubmed: 32229704 pmcid: 7219134
Kanayama G, Hudson JI, Pope HG Jr (2009) Features of men with anabolic-androgenic steroid dependence: a comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend 102:130–137
doi: 10.1016/j.drugalcdep.2009.02.008 pubmed: 19339124 pmcid: 2694450
Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S (2014) Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev 35:341–375. https://doi.org/10.1210/er.2013-1058
doi: 10.1210/er.2013-1058 pubmed: 24423981
Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ (2011) The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy 31:757–66
doi: 10.1592/phco.31.8.757 pubmed: 21923602
Parkinson AB, Evans NA (2006) Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc 38:644–651
doi: 10.1249/01.mss.0000210194.56834.5d pubmed: 16679978
Tahtamouni LH, Mustafa NH, Alfaouri AA, Hassan IM, Abdalla MY, Yasin SR (2008) Prevalence and risk factors for anabolic-androgenic steroid abuse among Jordanian collegiate students and athletes. Eur J Pub Health 18:661–665. https://doi.org/10.1093/eurpub/ckn062%JEuropeanJournalofPublicHealth
doi: 10.1093/eurpub/ckn062%JEuropeanJournalofPublicHealth
Skårberg K, Nyberg F, Engström I (2008) The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports. Subst Abuse Treat Prev Policy 3:1–10
doi: 10.1186/1747-597X-3-24
Brennan BP, Kanayama G, Hudson JI, Pope J, Harrison G (2011) Human growth hormone abuse in male weightlifters. Am J Addict 20:9–13
doi: 10.1111/j.1521-0391.2010.00093.x pubmed: 21175915
Prather ID, Brown DE, North P, Wilson JR (1995) Clenbuterol: a substitute for anabolic steroids? Med Sci Sports Exerc 27:1118–1121
doi: 10.1249/00005768-199508000-00003 pubmed: 7476054
Halabchi F, Esteghamati A, Razzaghi A, Noori A (2011) How the Iranian free-style wrestlers know and think about doping?–A knowledge and attitude study. World Acad Sci Eng Technol 59:209–214
Barghi TS, Halabchi F, Dvorak J, Hosseinnejad H (2015) How the Iranian football coaches and players know about doping? Asian J Sports Med 6(2):e24392
Reyes-Vallejo L (2020) Current use and abuse of anabolic steroids. Actas Urol Esp (English Edition) 44:309–313
doi: 10.1016/j.acuro.2019.10.011
WMA (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191–2194
doi: 10.1001/jama.2013.281053
Greenway CW, Price C (2018) A qualitative study of the motivations for anabolic-androgenic steroid use: the role of muscle dysmorphia and self-esteem in long-term users. Perform Enhanc Health 6:12–20
doi: 10.1016/j.peh.2018.02.002
Harris MA, Dunn M, Alwyn T (2016) A qualitative exploration of the motivations underlying anabolic-androgenic steroid use from adolescence into adulthood. Health Psychol Rep 4:315–320
doi: 10.5114/hpr.2016.61669
Kimergård A (2015) A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: motives, beliefs and experiences. J Subst Use 20:288–294
doi: 10.3109/14659891.2014.911977
Cohen J, Collins R, Darkes J, Gwartney D (2007) A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr 4:12
doi: 10.1186/1550-2783-4-12 pubmed: 17931410 pmcid: 2131752
Pysny L, Pysna J, Petru D, Ctvrteckova K, Aismann J (2019) A qualitative analysis of motivations for anabolic androgenic steroid use among non-competitive bodybuilders in the Czech Republic. J Phys Educ Sport 19:560–566
de Siqueira Nogueira FR, de Freitas BA, de Oliveira CVC, Vieira TI, Beniz Gouveia RL (2014) Anabolic–androgenic steroid use among Brazilian bodybuilders. Subst Use Misuse 49:1138–1145
doi: 10.3109/10826084.2014.912062
AlQayem F, ABFM MD, (2019) Prevalence, knowledge, attitude and practice of anabolic androgenic steroids use among adults male fitness centre attendees in Bahrain. Saudi Med J 4(7):545–550
Alsaeed I, Alabkal JR (2015) Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait-a cross-sectional study. Subst Abuse Treat Prev Policy 10:1–6
doi: 10.1186/s13011-015-0030-5
Jabari M, Al-Shehri H, Al-Faris A et al (2016) The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia). Electron Physician 8:3343
doi: 10.19082/3343 pubmed: 28163846 pmcid: 5279964
Al-Falasi O, Al-Dahmani K, Al-Eisaei K et al (2008) Knowledge, attitude and practice of anabolic steroids use among gym users in Al-Ain district, United Arab Emirates. Open Sports Med J 2:75–81
doi: 10.2174/1874387000802010075
Althobiti SD, Alqurashi NM, Alotaibi AS, Alharthi TF, Alswat KA (2018) Prevalence, attitude, knowledge, and practice of anabolic androgenic steroid (AAS) use among gym participants. Mater Sociomed 30:49
doi: 10.5455/msm.2018.30.49-52 pubmed: 29670477 pmcid: 5857039
Grace F, Baker J, Davies B (2001) Anabolic androgenic steroid use in recreational gym users: a regional sample of the Mid-Glamorgan area. J Subst Use 6:189–195
doi: 10.1080/14659890152558804
Iriart JAB, Chaves JC, Orleans RGd (2009) Culto ao corpo e uso de anabolizantes entre praticantes de musculação. Cad Saude Publica 25:773–782
doi: 10.1590/S0102-311X2009000400008 pubmed: 19347203
de Araújo LR, Andreolo J, Silva MS (2002) Utilização de suplemento alimentar e anabolizantes por praticantes de musculação nas academias de Goiânia-GO. Rev Bras Ciência Mov 10:13–18
da Silva PR, Machado Júnior LC, Figueiredo VC, Cioffi AP, Prestes MC, Czepielewski MA (2007) Prevalência do uso de agentes anabólicos em praticantes de musculação de Porto Alegre. Arq Bras Endocrinol Metabol 51:104–110
doi: 10.1590/S0004-27302007000100017 pubmed: 17435863
Pärssinen M, Seppälä T (2002) Steroid use and long-term health risks in former athletes. Sports Med 32:83–94
doi: 10.2165/00007256-200232020-00001 pubmed: 11817994

Auteurs

Nawal Izzat (N)

Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, P.O. Box 11937, Amman, Jordan.

Rana Abu-Farha (R)

Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, P.O. Box 11937, Amman, Jordan. r_abufarha@asu.edu.jo.

Mea'ad M Harahsheh (MM)

Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

Samar Thiab (S)

Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmacy, Applied Science Private University, Amman, Jordan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH